Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

301.79
+3.791.27%
Post-market: 301.790.00000.00%19:30 EDT
Volume:679.86K
Turnover:205.47M
Market Cap:14.41B
PE:-61.82
High:305.21
Open:294.60
Low:294.60
Close:298.00
52wk High:333.30
52wk Low:146.20
Shares:47.74M
Float Shares:47.20M
Volume Ratio:0.56
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:5.07
PE(LYR):-103.63

Loading ...

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
4 hours ago

Charles River Labs Schedules Third-Quarter 2026 Earnings Release, Conference Call

Reuters
·
Yesterday

Charles River Labs CEVP Shannon M. Parisotto Disposes of $302,579 in Common Shares

Reuters
·
Oct 08

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Oct 08

RBC Capital Remains a Buy on Charles River Labs (CRL)

TIPRANKS
·
Oct 07

Movement Alert|Charles River Laboratories Rises 5.24% in Regular Trading, UBS Upgrade and Digital Lab Collaboration Drive Gains

Market Focus
·
Oct 06

Charles River Partners with Autolomous to Roll Out Apollo Orchestrate Lab Execution System

Reuters
·
Oct 06

European Life Sciences Stocks Rise on Strong Sector Momentum

Reuters
·
Oct 06

Charles River Laboratories International Inc. Stock Rises 7.1%, Outperforms Peers

Dow Jones
·
Oct 06

Charles River Laboratories International Inc Stock (CRL) Closed Up by 7.09% on Oct 5: Key Drivers Unveiled

TradingKey
·
Oct 06

Charles River Laboratories on Track for Highest Close Since February 2022

Dow Jones
·
Oct 06

Movement Alert|Charles River Laboratories Intraday Rise 5.34%, UBS Upgrade and Probiotic Testing Agreement Drive Gains

Market Focus
·
Oct 05

What You Can Learn From Charles River Holders Who Are Up 64%

Simply Wall St.
·
Oct 04

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Oct 03

Charles River CFO Glenn Coleman Acquires 10 Common Shares Valued at $2,974.30

Reuters
·
Oct 03

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Oct 02

UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175

MT Newswires Live
·
Sep 30

Charles River Labs Price Target Announced at $357.00/Share by UBS

Dow Jones
·
Sep 30

PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing

MT Newswires Live
·
Sep 29

NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs

GlobeNewswire
·
Sep 29